Medical Care
Global Cancer Microbiome Testing Market Research Report 2025
- May 12, 25
- ID: 234803
- Pages: 79
- Figures: 80
- Views: 8
The global market for Cancer Microbiome Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Cancer Microbiome Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cancer Microbiome Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Cancer Microbiome Testing in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Cancer Microbiome Testing include CD Genomics, Eurofins Scientific, Illumina, Prescient Medicine Holding, Micronoma, Novogene, Oxford Nanopore Technologies, Pacific Biosciences, Qiagen, Therma Fisher Scientific, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cancer Microbiome Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Microbiome Testing.
The Cancer Microbiome Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancer Microbiome Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Microbiome Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CD Genomics
Eurofins Scientific
Illumina
Prescient Medicine Holding
Micronoma
Novogene
Oxford Nanopore Technologies
Pacific Biosciences
Qiagen
Therma Fisher Scientific
Segment by Type
Next Generation Sequencing
Polymerase Chain Reaction
Segment by Application
Hospitals
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Microbiome Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
North American market for Cancer Microbiome Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cancer Microbiome Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Cancer Microbiome Testing in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Cancer Microbiome Testing include CD Genomics, Eurofins Scientific, Illumina, Prescient Medicine Holding, Micronoma, Novogene, Oxford Nanopore Technologies, Pacific Biosciences, Qiagen, Therma Fisher Scientific, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cancer Microbiome Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Microbiome Testing.
The Cancer Microbiome Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancer Microbiome Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Microbiome Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
CD Genomics
Eurofins Scientific
Illumina
Prescient Medicine Holding
Micronoma
Novogene
Oxford Nanopore Technologies
Pacific Biosciences
Qiagen
Therma Fisher Scientific
Segment by Type
Next Generation Sequencing
Polymerase Chain Reaction
Segment by Application
Hospitals
Clinic
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Microbiome Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Microbiome Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Next Generation Sequencing
1.2.3 Polymerase Chain Reaction
1.3 Market by Application
1.3.1 Global Cancer Microbiome Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Microbiome Testing Market Perspective (2020-2031)
2.2 Global Cancer Microbiome Testing Growth Trends by Region
2.2.1 Global Cancer Microbiome Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cancer Microbiome Testing Historic Market Size by Region (2020-2025)
2.2.3 Cancer Microbiome Testing Forecasted Market Size by Region (2026-2031)
2.3 Cancer Microbiome Testing Market Dynamics
2.3.1 Cancer Microbiome Testing Industry Trends
2.3.2 Cancer Microbiome Testing Market Drivers
2.3.3 Cancer Microbiome Testing Market Challenges
2.3.4 Cancer Microbiome Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Microbiome Testing Players by Revenue
3.1.1 Global Top Cancer Microbiome Testing Players by Revenue (2020-2025)
3.1.2 Global Cancer Microbiome Testing Revenue Market Share by Players (2020-2025)
3.2 Global Cancer Microbiome Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cancer Microbiome Testing Revenue
3.4 Global Cancer Microbiome Testing Market Concentration Ratio
3.4.1 Global Cancer Microbiome Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Microbiome Testing Revenue in 2024
3.5 Global Key Players of Cancer Microbiome Testing Head office and Area Served
3.6 Global Key Players of Cancer Microbiome Testing, Product and Application
3.7 Global Key Players of Cancer Microbiome Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Microbiome Testing Breakdown Data by Type
4.1 Global Cancer Microbiome Testing Historic Market Size by Type (2020-2025)
4.2 Global Cancer Microbiome Testing Forecasted Market Size by Type (2026-2031)
5 Cancer Microbiome Testing Breakdown Data by Application
5.1 Global Cancer Microbiome Testing Historic Market Size by Application (2020-2025)
5.2 Global Cancer Microbiome Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cancer Microbiome Testing Market Size (2020-2031)
6.2 North America Cancer Microbiome Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cancer Microbiome Testing Market Size by Country (2020-2025)
6.4 North America Cancer Microbiome Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Microbiome Testing Market Size (2020-2031)
7.2 Europe Cancer Microbiome Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cancer Microbiome Testing Market Size by Country (2020-2025)
7.4 Europe Cancer Microbiome Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Microbiome Testing Market Size (2020-2031)
8.2 Asia-Pacific Cancer Microbiome Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cancer Microbiome Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Cancer Microbiome Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Microbiome Testing Market Size (2020-2031)
9.2 Latin America Cancer Microbiome Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cancer Microbiome Testing Market Size by Country (2020-2025)
9.4 Latin America Cancer Microbiome Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Microbiome Testing Market Size (2020-2031)
10.2 Middle East & Africa Cancer Microbiome Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cancer Microbiome Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Cancer Microbiome Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CD Genomics
11.1.1 CD Genomics Company Details
11.1.2 CD Genomics Business Overview
11.1.3 CD Genomics Cancer Microbiome Testing Introduction
11.1.4 CD Genomics Revenue in Cancer Microbiome Testing Business (2020-2025)
11.1.5 CD Genomics Recent Development
11.2 Eurofins Scientific
11.2.1 Eurofins Scientific Company Details
11.2.2 Eurofins Scientific Business Overview
11.2.3 Eurofins Scientific Cancer Microbiome Testing Introduction
11.2.4 Eurofins Scientific Revenue in Cancer Microbiome Testing Business (2020-2025)
11.2.5 Eurofins Scientific Recent Development
11.3 Illumina
11.3.1 Illumina Company Details
11.3.2 Illumina Business Overview
11.3.3 Illumina Cancer Microbiome Testing Introduction
11.3.4 Illumina Revenue in Cancer Microbiome Testing Business (2020-2025)
11.3.5 Illumina Recent Development
11.4 Prescient Medicine Holding
11.4.1 Prescient Medicine Holding Company Details
11.4.2 Prescient Medicine Holding Business Overview
11.4.3 Prescient Medicine Holding Cancer Microbiome Testing Introduction
11.4.4 Prescient Medicine Holding Revenue in Cancer Microbiome Testing Business (2020-2025)
11.4.5 Prescient Medicine Holding Recent Development
11.5 Micronoma
11.5.1 Micronoma Company Details
11.5.2 Micronoma Business Overview
11.5.3 Micronoma Cancer Microbiome Testing Introduction
11.5.4 Micronoma Revenue in Cancer Microbiome Testing Business (2020-2025)
11.5.5 Micronoma Recent Development
11.6 Novogene
11.6.1 Novogene Company Details
11.6.2 Novogene Business Overview
11.6.3 Novogene Cancer Microbiome Testing Introduction
11.6.4 Novogene Revenue in Cancer Microbiome Testing Business (2020-2025)
11.6.5 Novogene Recent Development
11.7 Oxford Nanopore Technologies
11.7.1 Oxford Nanopore Technologies Company Details
11.7.2 Oxford Nanopore Technologies Business Overview
11.7.3 Oxford Nanopore Technologies Cancer Microbiome Testing Introduction
11.7.4 Oxford Nanopore Technologies Revenue in Cancer Microbiome Testing Business (2020-2025)
11.7.5 Oxford Nanopore Technologies Recent Development
11.8 Pacific Biosciences
11.8.1 Pacific Biosciences Company Details
11.8.2 Pacific Biosciences Business Overview
11.8.3 Pacific Biosciences Cancer Microbiome Testing Introduction
11.8.4 Pacific Biosciences Revenue in Cancer Microbiome Testing Business (2020-2025)
11.8.5 Pacific Biosciences Recent Development
11.9 Qiagen
11.9.1 Qiagen Company Details
11.9.2 Qiagen Business Overview
11.9.3 Qiagen Cancer Microbiome Testing Introduction
11.9.4 Qiagen Revenue in Cancer Microbiome Testing Business (2020-2025)
11.9.5 Qiagen Recent Development
11.10 Therma Fisher Scientific
11.10.1 Therma Fisher Scientific Company Details
11.10.2 Therma Fisher Scientific Business Overview
11.10.3 Therma Fisher Scientific Cancer Microbiome Testing Introduction
11.10.4 Therma Fisher Scientific Revenue in Cancer Microbiome Testing Business (2020-2025)
11.10.5 Therma Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Microbiome Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Next Generation Sequencing
1.2.3 Polymerase Chain Reaction
1.3 Market by Application
1.3.1 Global Cancer Microbiome Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Microbiome Testing Market Perspective (2020-2031)
2.2 Global Cancer Microbiome Testing Growth Trends by Region
2.2.1 Global Cancer Microbiome Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cancer Microbiome Testing Historic Market Size by Region (2020-2025)
2.2.3 Cancer Microbiome Testing Forecasted Market Size by Region (2026-2031)
2.3 Cancer Microbiome Testing Market Dynamics
2.3.1 Cancer Microbiome Testing Industry Trends
2.3.2 Cancer Microbiome Testing Market Drivers
2.3.3 Cancer Microbiome Testing Market Challenges
2.3.4 Cancer Microbiome Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Microbiome Testing Players by Revenue
3.1.1 Global Top Cancer Microbiome Testing Players by Revenue (2020-2025)
3.1.2 Global Cancer Microbiome Testing Revenue Market Share by Players (2020-2025)
3.2 Global Cancer Microbiome Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cancer Microbiome Testing Revenue
3.4 Global Cancer Microbiome Testing Market Concentration Ratio
3.4.1 Global Cancer Microbiome Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Microbiome Testing Revenue in 2024
3.5 Global Key Players of Cancer Microbiome Testing Head office and Area Served
3.6 Global Key Players of Cancer Microbiome Testing, Product and Application
3.7 Global Key Players of Cancer Microbiome Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Microbiome Testing Breakdown Data by Type
4.1 Global Cancer Microbiome Testing Historic Market Size by Type (2020-2025)
4.2 Global Cancer Microbiome Testing Forecasted Market Size by Type (2026-2031)
5 Cancer Microbiome Testing Breakdown Data by Application
5.1 Global Cancer Microbiome Testing Historic Market Size by Application (2020-2025)
5.2 Global Cancer Microbiome Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cancer Microbiome Testing Market Size (2020-2031)
6.2 North America Cancer Microbiome Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cancer Microbiome Testing Market Size by Country (2020-2025)
6.4 North America Cancer Microbiome Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Microbiome Testing Market Size (2020-2031)
7.2 Europe Cancer Microbiome Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cancer Microbiome Testing Market Size by Country (2020-2025)
7.4 Europe Cancer Microbiome Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Microbiome Testing Market Size (2020-2031)
8.2 Asia-Pacific Cancer Microbiome Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cancer Microbiome Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Cancer Microbiome Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Microbiome Testing Market Size (2020-2031)
9.2 Latin America Cancer Microbiome Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cancer Microbiome Testing Market Size by Country (2020-2025)
9.4 Latin America Cancer Microbiome Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Microbiome Testing Market Size (2020-2031)
10.2 Middle East & Africa Cancer Microbiome Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cancer Microbiome Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Cancer Microbiome Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CD Genomics
11.1.1 CD Genomics Company Details
11.1.2 CD Genomics Business Overview
11.1.3 CD Genomics Cancer Microbiome Testing Introduction
11.1.4 CD Genomics Revenue in Cancer Microbiome Testing Business (2020-2025)
11.1.5 CD Genomics Recent Development
11.2 Eurofins Scientific
11.2.1 Eurofins Scientific Company Details
11.2.2 Eurofins Scientific Business Overview
11.2.3 Eurofins Scientific Cancer Microbiome Testing Introduction
11.2.4 Eurofins Scientific Revenue in Cancer Microbiome Testing Business (2020-2025)
11.2.5 Eurofins Scientific Recent Development
11.3 Illumina
11.3.1 Illumina Company Details
11.3.2 Illumina Business Overview
11.3.3 Illumina Cancer Microbiome Testing Introduction
11.3.4 Illumina Revenue in Cancer Microbiome Testing Business (2020-2025)
11.3.5 Illumina Recent Development
11.4 Prescient Medicine Holding
11.4.1 Prescient Medicine Holding Company Details
11.4.2 Prescient Medicine Holding Business Overview
11.4.3 Prescient Medicine Holding Cancer Microbiome Testing Introduction
11.4.4 Prescient Medicine Holding Revenue in Cancer Microbiome Testing Business (2020-2025)
11.4.5 Prescient Medicine Holding Recent Development
11.5 Micronoma
11.5.1 Micronoma Company Details
11.5.2 Micronoma Business Overview
11.5.3 Micronoma Cancer Microbiome Testing Introduction
11.5.4 Micronoma Revenue in Cancer Microbiome Testing Business (2020-2025)
11.5.5 Micronoma Recent Development
11.6 Novogene
11.6.1 Novogene Company Details
11.6.2 Novogene Business Overview
11.6.3 Novogene Cancer Microbiome Testing Introduction
11.6.4 Novogene Revenue in Cancer Microbiome Testing Business (2020-2025)
11.6.5 Novogene Recent Development
11.7 Oxford Nanopore Technologies
11.7.1 Oxford Nanopore Technologies Company Details
11.7.2 Oxford Nanopore Technologies Business Overview
11.7.3 Oxford Nanopore Technologies Cancer Microbiome Testing Introduction
11.7.4 Oxford Nanopore Technologies Revenue in Cancer Microbiome Testing Business (2020-2025)
11.7.5 Oxford Nanopore Technologies Recent Development
11.8 Pacific Biosciences
11.8.1 Pacific Biosciences Company Details
11.8.2 Pacific Biosciences Business Overview
11.8.3 Pacific Biosciences Cancer Microbiome Testing Introduction
11.8.4 Pacific Biosciences Revenue in Cancer Microbiome Testing Business (2020-2025)
11.8.5 Pacific Biosciences Recent Development
11.9 Qiagen
11.9.1 Qiagen Company Details
11.9.2 Qiagen Business Overview
11.9.3 Qiagen Cancer Microbiome Testing Introduction
11.9.4 Qiagen Revenue in Cancer Microbiome Testing Business (2020-2025)
11.9.5 Qiagen Recent Development
11.10 Therma Fisher Scientific
11.10.1 Therma Fisher Scientific Company Details
11.10.2 Therma Fisher Scientific Business Overview
11.10.3 Therma Fisher Scientific Cancer Microbiome Testing Introduction
11.10.4 Therma Fisher Scientific Revenue in Cancer Microbiome Testing Business (2020-2025)
11.10.5 Therma Fisher Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Cancer Microbiome Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Next Generation Sequencing
Table 3. Key Players of Polymerase Chain Reaction
Table 4. Global Cancer Microbiome Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Cancer Microbiome Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Cancer Microbiome Testing Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Cancer Microbiome Testing Market Share by Region (2020-2025)
Table 8. Global Cancer Microbiome Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Cancer Microbiome Testing Market Share by Region (2026-2031)
Table 10. Cancer Microbiome Testing Market Trends
Table 11. Cancer Microbiome Testing Market Drivers
Table 12. Cancer Microbiome Testing Market Challenges
Table 13. Cancer Microbiome Testing Market Restraints
Table 14. Global Cancer Microbiome Testing Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Cancer Microbiome Testing Market Share by Players (2020-2025)
Table 16. Global Top Cancer Microbiome Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Microbiome Testing as of 2024)
Table 17. Ranking of Global Top Cancer Microbiome Testing Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Cancer Microbiome Testing Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Cancer Microbiome Testing, Headquarters and Area Served
Table 20. Global Key Players of Cancer Microbiome Testing, Product and Application
Table 21. Global Key Players of Cancer Microbiome Testing, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cancer Microbiome Testing Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Cancer Microbiome Testing Revenue Market Share by Type (2020-2025)
Table 25. Global Cancer Microbiome Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Cancer Microbiome Testing Revenue Market Share by Type (2026-2031)
Table 27. Global Cancer Microbiome Testing Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Cancer Microbiome Testing Revenue Market Share by Application (2020-2025)
Table 29. Global Cancer Microbiome Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Cancer Microbiome Testing Revenue Market Share by Application (2026-2031)
Table 31. North America Cancer Microbiome Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Cancer Microbiome Testing Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Cancer Microbiome Testing Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Cancer Microbiome Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Cancer Microbiome Testing Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Cancer Microbiome Testing Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Cancer Microbiome Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Cancer Microbiome Testing Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Cancer Microbiome Testing Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Cancer Microbiome Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Cancer Microbiome Testing Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Cancer Microbiome Testing Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Cancer Microbiome Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Cancer Microbiome Testing Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Cancer Microbiome Testing Market Size by Country (2026-2031) & (US$ Million)
Table 46. CD Genomics Company Details
Table 47. CD Genomics Business Overview
Table 48. CD Genomics Cancer Microbiome Testing Product
Table 49. CD Genomics Revenue in Cancer Microbiome Testing Business (2020-2025) & (US$ Million)
Table 50. CD Genomics Recent Development
Table 51. Eurofins Scientific Company Details
Table 52. Eurofins Scientific Business Overview
Table 53. Eurofins Scientific Cancer Microbiome Testing Product
Table 54. Eurofins Scientific Revenue in Cancer Microbiome Testing Business (2020-2025) & (US$ Million)
Table 55. Eurofins Scientific Recent Development
Table 56. Illumina Company Details
Table 57. Illumina Business Overview
Table 58. Illumina Cancer Microbiome Testing Product
Table 59. Illumina Revenue in Cancer Microbiome Testing Business (2020-2025) & (US$ Million)
Table 60. Illumina Recent Development
Table 61. Prescient Medicine Holding Company Details
Table 62. Prescient Medicine Holding Business Overview
Table 63. Prescient Medicine Holding Cancer Microbiome Testing Product
Table 64. Prescient Medicine Holding Revenue in Cancer Microbiome Testing Business (2020-2025) & (US$ Million)
Table 65. Prescient Medicine Holding Recent Development
Table 66. Micronoma Company Details
Table 67. Micronoma Business Overview
Table 68. Micronoma Cancer Microbiome Testing Product
Table 69. Micronoma Revenue in Cancer Microbiome Testing Business (2020-2025) & (US$ Million)
Table 70. Micronoma Recent Development
Table 71. Novogene Company Details
Table 72. Novogene Business Overview
Table 73. Novogene Cancer Microbiome Testing Product
Table 74. Novogene Revenue in Cancer Microbiome Testing Business (2020-2025) & (US$ Million)
Table 75. Novogene Recent Development
Table 76. Oxford Nanopore Technologies Company Details
Table 77. Oxford Nanopore Technologies Business Overview
Table 78. Oxford Nanopore Technologies Cancer Microbiome Testing Product
Table 79. Oxford Nanopore Technologies Revenue in Cancer Microbiome Testing Business (2020-2025) & (US$ Million)
Table 80. Oxford Nanopore Technologies Recent Development
Table 81. Pacific Biosciences Company Details
Table 82. Pacific Biosciences Business Overview
Table 83. Pacific Biosciences Cancer Microbiome Testing Product
Table 84. Pacific Biosciences Revenue in Cancer Microbiome Testing Business (2020-2025) & (US$ Million)
Table 85. Pacific Biosciences Recent Development
Table 86. Qiagen Company Details
Table 87. Qiagen Business Overview
Table 88. Qiagen Cancer Microbiome Testing Product
Table 89. Qiagen Revenue in Cancer Microbiome Testing Business (2020-2025) & (US$ Million)
Table 90. Qiagen Recent Development
Table 91. Therma Fisher Scientific Company Details
Table 92. Therma Fisher Scientific Business Overview
Table 93. Therma Fisher Scientific Cancer Microbiome Testing Product
Table 94. Therma Fisher Scientific Revenue in Cancer Microbiome Testing Business (2020-2025) & (US$ Million)
Table 95. Therma Fisher Scientific Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. Cancer Microbiome Testing Picture
Figure 2. Global Cancer Microbiome Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cancer Microbiome Testing Market Share by Type: 2024 VS 2031
Figure 4. Next Generation Sequencing Features
Figure 5. Polymerase Chain Reaction Features
Figure 6. Global Cancer Microbiome Testing Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Cancer Microbiome Testing Market Share by Application: 2024 VS 2031
Figure 8. Hospitals Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Cancer Microbiome Testing Report Years Considered
Figure 12. Global Cancer Microbiome Testing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Cancer Microbiome Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Cancer Microbiome Testing Market Share by Region: 2024 VS 2031
Figure 15. Global Cancer Microbiome Testing Market Share by Players in 2024
Figure 16. Global Top Cancer Microbiome Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Microbiome Testing as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Cancer Microbiome Testing Revenue in 2024
Figure 18. North America Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Cancer Microbiome Testing Market Share by Country (2020-2031)
Figure 20. United States Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Cancer Microbiome Testing Market Share by Country (2020-2031)
Figure 24. Germany Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Cancer Microbiome Testing Market Share by Region (2020-2031)
Figure 32. China Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Cancer Microbiome Testing Market Share by Country (2020-2031)
Figure 40. Mexico Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Cancer Microbiome Testing Market Share by Country (2020-2031)
Figure 44. Turkey Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. CD Genomics Revenue Growth Rate in Cancer Microbiome Testing Business (2020-2025)
Figure 48. Eurofins Scientific Revenue Growth Rate in Cancer Microbiome Testing Business (2020-2025)
Figure 49. Illumina Revenue Growth Rate in Cancer Microbiome Testing Business (2020-2025)
Figure 50. Prescient Medicine Holding Revenue Growth Rate in Cancer Microbiome Testing Business (2020-2025)
Figure 51. Micronoma Revenue Growth Rate in Cancer Microbiome Testing Business (2020-2025)
Figure 52. Novogene Revenue Growth Rate in Cancer Microbiome Testing Business (2020-2025)
Figure 53. Oxford Nanopore Technologies Revenue Growth Rate in Cancer Microbiome Testing Business (2020-2025)
Figure 54. Pacific Biosciences Revenue Growth Rate in Cancer Microbiome Testing Business (2020-2025)
Figure 55. Qiagen Revenue Growth Rate in Cancer Microbiome Testing Business (2020-2025)
Figure 56. Therma Fisher Scientific Revenue Growth Rate in Cancer Microbiome Testing Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Table 1. Global Cancer Microbiome Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Next Generation Sequencing
Table 3. Key Players of Polymerase Chain Reaction
Table 4. Global Cancer Microbiome Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Cancer Microbiome Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Cancer Microbiome Testing Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Cancer Microbiome Testing Market Share by Region (2020-2025)
Table 8. Global Cancer Microbiome Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Cancer Microbiome Testing Market Share by Region (2026-2031)
Table 10. Cancer Microbiome Testing Market Trends
Table 11. Cancer Microbiome Testing Market Drivers
Table 12. Cancer Microbiome Testing Market Challenges
Table 13. Cancer Microbiome Testing Market Restraints
Table 14. Global Cancer Microbiome Testing Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Cancer Microbiome Testing Market Share by Players (2020-2025)
Table 16. Global Top Cancer Microbiome Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Microbiome Testing as of 2024)
Table 17. Ranking of Global Top Cancer Microbiome Testing Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Cancer Microbiome Testing Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Cancer Microbiome Testing, Headquarters and Area Served
Table 20. Global Key Players of Cancer Microbiome Testing, Product and Application
Table 21. Global Key Players of Cancer Microbiome Testing, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cancer Microbiome Testing Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Cancer Microbiome Testing Revenue Market Share by Type (2020-2025)
Table 25. Global Cancer Microbiome Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Cancer Microbiome Testing Revenue Market Share by Type (2026-2031)
Table 27. Global Cancer Microbiome Testing Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Cancer Microbiome Testing Revenue Market Share by Application (2020-2025)
Table 29. Global Cancer Microbiome Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Cancer Microbiome Testing Revenue Market Share by Application (2026-2031)
Table 31. North America Cancer Microbiome Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Cancer Microbiome Testing Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Cancer Microbiome Testing Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Cancer Microbiome Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Cancer Microbiome Testing Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Cancer Microbiome Testing Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Cancer Microbiome Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Cancer Microbiome Testing Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Cancer Microbiome Testing Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Cancer Microbiome Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Cancer Microbiome Testing Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Cancer Microbiome Testing Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Cancer Microbiome Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Cancer Microbiome Testing Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Cancer Microbiome Testing Market Size by Country (2026-2031) & (US$ Million)
Table 46. CD Genomics Company Details
Table 47. CD Genomics Business Overview
Table 48. CD Genomics Cancer Microbiome Testing Product
Table 49. CD Genomics Revenue in Cancer Microbiome Testing Business (2020-2025) & (US$ Million)
Table 50. CD Genomics Recent Development
Table 51. Eurofins Scientific Company Details
Table 52. Eurofins Scientific Business Overview
Table 53. Eurofins Scientific Cancer Microbiome Testing Product
Table 54. Eurofins Scientific Revenue in Cancer Microbiome Testing Business (2020-2025) & (US$ Million)
Table 55. Eurofins Scientific Recent Development
Table 56. Illumina Company Details
Table 57. Illumina Business Overview
Table 58. Illumina Cancer Microbiome Testing Product
Table 59. Illumina Revenue in Cancer Microbiome Testing Business (2020-2025) & (US$ Million)
Table 60. Illumina Recent Development
Table 61. Prescient Medicine Holding Company Details
Table 62. Prescient Medicine Holding Business Overview
Table 63. Prescient Medicine Holding Cancer Microbiome Testing Product
Table 64. Prescient Medicine Holding Revenue in Cancer Microbiome Testing Business (2020-2025) & (US$ Million)
Table 65. Prescient Medicine Holding Recent Development
Table 66. Micronoma Company Details
Table 67. Micronoma Business Overview
Table 68. Micronoma Cancer Microbiome Testing Product
Table 69. Micronoma Revenue in Cancer Microbiome Testing Business (2020-2025) & (US$ Million)
Table 70. Micronoma Recent Development
Table 71. Novogene Company Details
Table 72. Novogene Business Overview
Table 73. Novogene Cancer Microbiome Testing Product
Table 74. Novogene Revenue in Cancer Microbiome Testing Business (2020-2025) & (US$ Million)
Table 75. Novogene Recent Development
Table 76. Oxford Nanopore Technologies Company Details
Table 77. Oxford Nanopore Technologies Business Overview
Table 78. Oxford Nanopore Technologies Cancer Microbiome Testing Product
Table 79. Oxford Nanopore Technologies Revenue in Cancer Microbiome Testing Business (2020-2025) & (US$ Million)
Table 80. Oxford Nanopore Technologies Recent Development
Table 81. Pacific Biosciences Company Details
Table 82. Pacific Biosciences Business Overview
Table 83. Pacific Biosciences Cancer Microbiome Testing Product
Table 84. Pacific Biosciences Revenue in Cancer Microbiome Testing Business (2020-2025) & (US$ Million)
Table 85. Pacific Biosciences Recent Development
Table 86. Qiagen Company Details
Table 87. Qiagen Business Overview
Table 88. Qiagen Cancer Microbiome Testing Product
Table 89. Qiagen Revenue in Cancer Microbiome Testing Business (2020-2025) & (US$ Million)
Table 90. Qiagen Recent Development
Table 91. Therma Fisher Scientific Company Details
Table 92. Therma Fisher Scientific Business Overview
Table 93. Therma Fisher Scientific Cancer Microbiome Testing Product
Table 94. Therma Fisher Scientific Revenue in Cancer Microbiome Testing Business (2020-2025) & (US$ Million)
Table 95. Therma Fisher Scientific Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
Table 99. Authors List of This Report
List of Figures
Figure 1. Cancer Microbiome Testing Picture
Figure 2. Global Cancer Microbiome Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cancer Microbiome Testing Market Share by Type: 2024 VS 2031
Figure 4. Next Generation Sequencing Features
Figure 5. Polymerase Chain Reaction Features
Figure 6. Global Cancer Microbiome Testing Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Cancer Microbiome Testing Market Share by Application: 2024 VS 2031
Figure 8. Hospitals Case Studies
Figure 9. Clinic Case Studies
Figure 10. Others Case Studies
Figure 11. Cancer Microbiome Testing Report Years Considered
Figure 12. Global Cancer Microbiome Testing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Cancer Microbiome Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Cancer Microbiome Testing Market Share by Region: 2024 VS 2031
Figure 15. Global Cancer Microbiome Testing Market Share by Players in 2024
Figure 16. Global Top Cancer Microbiome Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Microbiome Testing as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Cancer Microbiome Testing Revenue in 2024
Figure 18. North America Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Cancer Microbiome Testing Market Share by Country (2020-2031)
Figure 20. United States Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Cancer Microbiome Testing Market Share by Country (2020-2031)
Figure 24. Germany Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Cancer Microbiome Testing Market Share by Region (2020-2031)
Figure 32. China Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Cancer Microbiome Testing Market Share by Country (2020-2031)
Figure 40. Mexico Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Cancer Microbiome Testing Market Share by Country (2020-2031)
Figure 44. Turkey Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Cancer Microbiome Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. CD Genomics Revenue Growth Rate in Cancer Microbiome Testing Business (2020-2025)
Figure 48. Eurofins Scientific Revenue Growth Rate in Cancer Microbiome Testing Business (2020-2025)
Figure 49. Illumina Revenue Growth Rate in Cancer Microbiome Testing Business (2020-2025)
Figure 50. Prescient Medicine Holding Revenue Growth Rate in Cancer Microbiome Testing Business (2020-2025)
Figure 51. Micronoma Revenue Growth Rate in Cancer Microbiome Testing Business (2020-2025)
Figure 52. Novogene Revenue Growth Rate in Cancer Microbiome Testing Business (2020-2025)
Figure 53. Oxford Nanopore Technologies Revenue Growth Rate in Cancer Microbiome Testing Business (2020-2025)
Figure 54. Pacific Biosciences Revenue Growth Rate in Cancer Microbiome Testing Business (2020-2025)
Figure 55. Qiagen Revenue Growth Rate in Cancer Microbiome Testing Business (2020-2025)
Figure 56. Therma Fisher Scientific Revenue Growth Rate in Cancer Microbiome Testing Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232